Gevorg Tamamyan, MD, MSc, PhD, DSc is the CEO of the Immune Oncology Research Institute, the Head of the Pediatric Cancer and Blood Disorders Center of Armenia, Chairman and Professor of the Department of Pediatric Oncology and Hematology of Yerevan State Medical University (YSMU). Dr. Tamamyan is also the adviser to the Rector of YSMU and the adviser to the Director of the Yeolyan Hematology and Oncology Center.
Dr. Tamamyan is the President-Elect of the Pediatric Oncology East and Mediterranean (POEM) Group, which assembles 110 pediatric cancer centers from 28 countries. He was the chairman of the American Society of Clinical Oncology (ASCO) IDEA steering group and co-chairman of the International Society of Pediatric Oncology (SIOP) PODC Supportive care working group. He is the ambassador of the Society of Hematologic Oncology, chairman of the Armenian Pediatric Hematology and Oncology Group and Chairman of the Board and co-founder of the Institute of Cancer and Crisis.
He is a co-founder of the Armenian Association of Hematology and Oncology, a co-founder and a Board Member of the City of Smile Foundation, the largest cancer charity in Armenia, and co-founder of the 4090 charitable foundation. He was the 2018-2019 President of the Harvard Club of Armenia.
MD and PhD degrees, he received from YSMU, MSc from the University of Ulm (Germany), where he currently also lectures pediatric oncology. He completed postdoc in leukemia at the University of Texas MD Anderson Cancer Center (USA), visiting fellowships at China Medical University Hospital (Taiwan) and St. Anna Children’s Hospital (Austria), was a medical research fellow at the Headquarters of the European Organization for Research and Treatment of Cancer (Belgium), visiting scientist at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center (USA), completed High-Impact Cancer Research postgraduate program at the Harvard Medical School (USA), Global Health Delivery Intensive Course at the Harvard School of Public Health (USA) and Global Health Diplomacy Executive Course at the University of Toronto (Canada).
He is a recipient of numerous awards and distinctions, among them the ASCO IDEA (2013) and LIFe (2014) Awards, 40 Under 40 in Cancer Award (2022), he was recognized as a Young Leader of the International Agency for Cancer Research (2016) and Union for International Cancer Control (2016), and selected for the ASCO Leadership Development Program (2022).
He is married and has two daughters - Charlize and Letizia.
About IMMONC
Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048.